tirzepatide vs dulaglutide Ongoing #GLP1 -RA Trials on #ASCVD #SELECT: Semaglutide Placebo in Patients With Obesity and ASCVD Without DM #SOUL: Semaglutide vs Placebo in Adults With T2D With ASCVD or CKD #SURPASS-CVOT: Tirzepatide vs. Dulaglutide: Cardiovascular Outcomes

The Science Behind Anti-Aging: Going Deep for Ageless Results with Non-Surgical Anti-Aging Treatments Is the Vi Peel Your One-Way Ticket to a Revitalized Complexion

could see a decline in cases as the utilization of GLP-1 receptor agonists rises

Real-world dosing patterns and what the data shows While no clinical trial has tested five-day dosing, real-world prescribing data provides some insight into what happens when patients deviate from the weekly schedule

The L-Carnitine 50 mg/ml Oral Liquid formulation is designed to provide a precise dose of this essential compound in a liquid form, which is particularly beneficial for patients who have difficulty swallowing pills or tablets, such as children and the elderly

Investors are waiting for Pfizer to release phase two trial data on its twice-daily pill, in obese patients without diabetes, by the end of the year